InstruNor
About InstruNor
InstruNor is a Healthcare company founded in 2011, and was acquired by Fluidigm in February 2020. Manufacturer of cancer and immune system treatment devices. Its focus areas include Traditional Medical Devices.
Company details
InstruNor manufacturer of cancer and immune system treatment devices, focusing on providing healthcare solutions, and traditional medical devices. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets. It continues to evolve, meeting industry challenges with strategic approaches.
- Stage Acquired
- SectorsHealthcare
- Website instrunor.com
- Acquired by Fluidigm (Feb 2020)
Investors in InstruNor
InstruNor has secured backing from 1 investor. Prominent investors backing the company include Fluidigm.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Instruments for life sciences research and applications are developed. | 1999 | fluidigm.com | San Francisco, United States |
Investor details for InstruNor
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of InstruNor
2 dated milestones of InstruNor across 9 years, from founding to its latest funding, stage changes and deals.
- Founded InstruNor is founded.
- Exit Acquired by Fluidigm.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about InstruNor
InstruNor was founded in 2011.
Annual revenue of InstruNor is $203.33K as on Dec 31, 2021.
InstruNor manufacturer of cancer and immune system treatment devices, focusing on providing healthcare solutions, and traditional medical devices. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets. It continues to evolve, meeting industry challenges with strategic approaches.
InstruNor has 1 investor. Key investors include Fluidigm.
Yes. InstruNor was acquired by Fluidigm in February 2020.